Information:
Fel:
ID
44054
Beskrivning
Study part: Status of treatment blind. A phase 1 single-masked, randomized (with respect to placebo), placebo-controlled, parallel-group, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of repeat oral doses of GW786034 in elderly healthy volunteers. Trade Name: Votrient. Clinical Study ID: MD1103367.
Nyckelord
Versioner (2)
- 2018-06-19 2018-06-19 -
- 2021-09-20 2021-09-20 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
20 september 2021
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Status of treatment blind Pazopanib Macular Degeneration MD1103367
Similar models
Status of treatment blind
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
STATUS OF TREATMENT BLIND (Blind)
C0749659 (UMLS CUI-1)
C2347038 (UMLS CUI-2)
C2347038 (UMLS CUI-2)
Item
Was the treatment blind broken during the study?
text
C0749659 (UMLS CUI [1])
C2347038 (UMLS CUI [2])
C2347038 (UMLS CUI [2])
CL Item
No (N)
CL Item
Yes (Y)
Date and time Blinded Clinical Study study end
Item
Date/time blind broken
datetime
C1264639 (UMLS CUI [1,1])
C2347038 (UMLS CUI [1,2])
C2983670 (UMLS CUI [1,3])
C2347038 (UMLS CUI [1,2])
C2983670 (UMLS CUI [1,3])
CL Item
Medical emergency requiring identification of investigational product for further treatment (Medical emergency requiring identification of investigational product for further treatment)
CL Item
Other (Other)
Other
Item
Other, specify
text
C0205394 (UMLS CUI [1])